Need Help?

Whole genome sequencing

16 CRC patient WGS data

Request Access

The committee reviews data access request to the dataset obtained from proteomics projects.

1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify the MSKCC Proteogenomics Data Access Committee within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify the MSKCC Proteogenomics Data Access Committee prior to any significant changes to the protocol for the Project. 14. The User Institution will notify the MSKCC Proteogenomics Data Access Committee as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. The MSKCC Proteogenomics Data Access Committee may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than the MSKCC Proteogenomics Data Access Committee. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001006465 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00006609274 bam 107.6 GB
EGAF00006609275 bam 196.5 GB
EGAF00006609276 bam 107.6 GB
EGAF00006609277 bam 210.5 GB
EGAF00006609284 bam 112.2 GB
EGAF00006609285 bam 245.1 GB
EGAF00006609286 bam 112.2 GB
EGAF00006609287 bam 241.0 GB
EGAF00006609294 bam 107.6 GB
EGAF00006609295 bam 216.5 GB
EGAF00006609296 bam 107.6 GB
EGAF00006609297 bam 217.6 GB
EGAF00006609304 bam 117.3 GB
EGAF00006609305 bam 220.7 GB
EGAF00006609306 bam 117.3 GB
EGAF00006609307 bam 207.7 GB
EGAF00006609314 bam 123.2 GB
EGAF00006609315 bam 234.7 GB
EGAF00006609316 bam 123.2 GB
EGAF00006609317 bam 251.8 GB
EGAF00006609324 bam 123.2 GB
EGAF00006609325 bam 170.5 GB
EGAF00006609326 bam 123.2 GB
EGAF00006609327 bam 228.9 GB
EGAF00006609334 bam 113.8 GB
EGAF00006609335 bam 233.0 GB
EGAF00006609336 bam 113.8 GB
EGAF00006609337 bam 222.5 GB
EGAF00006609344 bam 124.2 GB
EGAF00006609345 bam 234.6 GB
EGAF00006609346 bam 124.2 GB
EGAF00006609347 bam 203.0 GB
EGAF00006609354 bam 96.8 GB
EGAF00006609355 bam 214.2 GB
EGAF00006609356 bam 96.8 GB
EGAF00006609357 bam 167.5 GB
EGAF00006609364 bam 90.9 GB
EGAF00006609365 bam 208.1 GB
EGAF00006609366 bam 90.9 GB
EGAF00006609367 bam 218.1 GB
EGAF00006609374 bam 86.5 GB
EGAF00006609375 bam 202.0 GB
EGAF00006609376 bam 86.5 GB
EGAF00006609377 bam 250.1 GB
EGAF00006609384 bam 124.4 GB
EGAF00006609385 bam 224.2 GB
EGAF00006609386 bam 124.4 GB
EGAF00006609387 bam 233.8 GB
EGAF00006609394 bam 133.5 GB
EGAF00006609395 bam 174.9 GB
EGAF00006609396 bam 133.5 GB
EGAF00006609397 bam 237.5 GB
EGAF00006609404 bam 119.9 GB
EGAF00006609405 bam 209.7 GB
EGAF00006609406 bam 119.9 GB
EGAF00006609407 bam 234.3 GB
EGAF00006609414 bam 111.6 GB
EGAF00006609415 bam 234.0 GB
EGAF00006609416 bam 111.6 GB
EGAF00006609417 bam 193.5 GB
EGAF00006609424 bam 110.3 GB
EGAF00006609425 bam 237.2 GB
EGAF00006609426 bam 110.3 GB
EGAF00006609427 bam 209.5 GB
64 Files (10.6 TB)